IMPAVIDO 10 MG Israel - English - Ministry of Health

impavido 10 mg

megapharm ltd - miltefosine - hard capsule - miltefosine 10 mg - miltefosine - -treatment of visceral leishmaniasis caused by leishmania donovani. -treatment of cutaneous leishmaniasis caused by leishmania brasiliensis complex or leishmania mexicana complex.

IMPAVIDO 10 MG Israel - English - Ministry of Health

impavido 10 mg

megapharm ltd - miltefosine - hard capsule - miltefosine 10 mg - miltefosine - -treatment of visceral leishmaniasis caused by leishmania donovani. -treatment of cutaneous leishmaniasis caused by leishmania brasiliensis complex or leishmania mexicana complex.

IMPAVIDO 50 MG Israel - English - Ministry of Health

impavido 50 mg

megapharm ltd - miltefosine - hard capsule - miltefosine 50 mg - miltefosine - -treatment of visceral leishmaniasis caused by leishmania donovani. -treatment of cutaneous leishmaniasis caused by leishmania brasiliensis complex or leishmania mexicana complex.

IMPAVIDO 50 MG Israel - English - Ministry of Health

impavido 50 mg

megapharm ltd - miltefosine - hard capsule - miltefosine 50 mg - miltefosine - -treatment of visceral leishmaniasis caused by leishmania donovani. -treatment of cutaneous leishmaniasis caused by leishmania brasiliensis complex or leishmania mexicana complex.

Irinotecan 20 mg/ml Concentrate for solution for infusion Ireland - English - HPRA (Health Products Regulatory Authority)

irinotecan 20 mg/ml concentrate for solution for infusion

fresenius kabi oncology plc - irinotecan hydrochloride trihydrate - concentrate for solution for infusion - 20 milligram(s)/millilitre - other antineoplastic agents; miltefosine

Irinotecan 20 mg/ml Concentrate for solution for infusion Ireland - English - HPRA (Health Products Regulatory Authority)

irinotecan 20 mg/ml concentrate for solution for infusion

fresenius kabi deutschland gmbh - irinotecan - concentrate for solution for infusion - 20 milligram(s)/millilitre - other antineoplastic agents; miltefosine